Cargando…

Conscious Sedation Efficacy of 0.3 and 0.5 mg/kg Oral Midazolam for Three to Six Year-Old Uncooperative Children Undergoing Dental Treatment: A Clinical Trial

OBJECTIVES: Midazolam with variable dosages has been used to induce sedation in pediatric dentistry. The aim of this study was to compare the efficacy of two dosages of oral midazolam for conscious sedation of children undergoing dental treatment. MATERIALS AND METHODS: In this randomized crossover...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghajari, Masoud Fallahinejad, Ansari, Ghassem, Hasanbeygi, Leila, Shayeghi, Shahnaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139927/ https://www.ncbi.nlm.nih.gov/pubmed/27928238

Ejemplares similares

Comparison of Oral and Intranasal Midazolam/Ketamine Sedation in 3-6-year-old Uncooperative Dental Patients
por: Fallahinejad Ghajari, Masoud, et al.
Publicado: (2015)

Sedative Effect of Oral Midazolam/Hydroxyzine versus Chloral Hydrate/Hydroxyzine on 2–6 Year-Old Uncooperative Dental Patients: A Randomized Clinical Trial
por: Ghajari, Masoud Fallahinejad, et al.
Publicado: (2014)

Intranasal Premedication Effect of Dexmedetomidine Versus Midazolam on the Behavior of 2-6-Year-Old Uncooperative Children in Dental Clinic
por: Mahdavi, Alireza, et al.
Publicado: (2018)

Oral Melatonin Versus Midazolam as Premedication for Intravenous Sedation in Pediatric Dental Patients
por: Ansari, Ghassem, et al.
Publicado: (2018)

Comparison of oral Midazolam-Ketamine and Midazolam-Promethazine as sedative agents in pediatric dentistry
por: Golpayegani, Mojtaba Vahid, et al.
Publicado: (2012)

Comparison of sedative effects of oral midazolam/chloral hydrate and midazolam/promethazine in pediatric dentistry
por: Mehran, Majid, et al.
Publicado: (2018)

Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
por: Lytvyn, Yuliya, et al.
Publicado: (2022)

Epidermolysis Bullosa, Dental and Anesthetic Management: A Case Report
por: Esfahanizade, Katayoun, et al.
Publicado: (2014)

Evaluation of the Efficacy of Nasal Sedation Midazolam Compared with Dexmedetomidine in the Management of Uncooperative Children with Down Syndrome during Dental Treatment
por: Hamod, Mohamad Nabil, et al.
Publicado: (2022)

Penetration of 0.3% ciprofloxacin, 0.3% ofloxacin, and 0.5% moxifloxacin into the cornea and aqueous humor of enucleated human eyes
por: Silva, G.C.M., et al.
Publicado: (2017)

Comparative Evaluation of Ease of Dental Treatment and Clinical Efficiency of Midazolam vs Midazolam and Ketamine Combination for Sedation in Young Uncooperative Pediatric Patients: A Systematic Review
por: Rathi, Gauri Vijaykumar, et al.
Publicado: (2022)

Review of Loteprednol Etabonate 0.5%/Tobramycin 0.3% in the Treatment of Blepharokeratoconjunctivitis
por: Mah, Francis S., et al.
Publicado: (2021)

Modified electroconvulsive therapy in a resource-challenged setting: Comparison of two doses (0.5 mg/kg and 1 mg/kg) of suxamethonium chloride
por: Aaron, Olurotimi I., et al.
Publicado: (2020)

Comparative evaluation of bispectral index system after sedation with midazolam and propofol combined with remifentanil versus ketamine in uncooperative during dental procedures
por: Eshghi, Alireza, et al.
Publicado: (2016)

Adverse events of conscious sedation using midazolam for gastrointestinal endoscopy
por: Jun, Jeeyoung, et al.
Publicado: (2019)

Comparison of nitrous oxide/midazolam and nitrous oxide/promethazine for pediatric dental sedation: A randomized, cross-over, clinical trial
por: Mozafar, Sedigheh, et al.
Publicado: (2018)

Crystal chemistry and compressibility of Fe(0.5)Mg(0.5)Al(0.5)Si(0.5)O(3) and FeMg(0.5)Si(0.5)O(3) silicate perovskites at pressures up to 95 GPa
por: Koemets, Iuliia, et al.
Publicado: (2023)

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
por: Schnober, Dietmar, et al.
Publicado: (2015)

Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%)
por: Gheith, Moataz E, et al.
Publicado: (2008)

Effect of Intranasal Sedation Using Ketamine and Midazolam on Behavior of 3–6 Year-Old Uncooperative Children in Dental Office: A Clinical Trial
por: Mehran, Majid, et al.
Publicado: (2017)

Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial
por: Goldberg, Ivan, et al.
Publicado: (2014)

Efficacy and safety of EBUS‐TBNA under conscious sedation with meperidine and midazolam
por: Piro, Roberto, et al.
Publicado: (2022)

Re-audit of the use of flumazenil following midazolam-induced conscious sedation
por: Rosli, Muhammad Syafiq Asyraf, et al.
Publicado: (2023)

Study of the Influence of Zirconium, Titanium and Strontium on the Properties and Microstructure of AlSi7Mg0.3Cu0.5 Alloy
por: Bolibruchová, Dana, et al.
Publicado: (2022)

Comparison of Drug Concentrations in Human Aqueous Humor after the Administration of 0.3% Gatifloxacin Ophthalmic Gel, 0.3% Gatifloxacin and 0.5% Levofloxacin Ophthalmic Solutions
por: Ding, Wenting, et al.
Publicado: (2015)

Comparative Investigation of 0.5Li(2)MnO(3)·0.5LiNi(0.5)Co(0.2)Mn(0.3)O(2) Cathode Materials Synthesized by Using Different Lithium Sources
por: Wang, Peng-Bo, et al.
Publicado: (2018)

Rocuronium 0.3 or 0.9 mg/kg comparing onset time, duration of action, and intubating conditions in patients 80 years and older: A randomized study
por: Vested, Matias, et al.
Publicado: (2022)

Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice
por: Pfennigsdorf, Stefan, et al.
Publicado: (2016)

Anisotropic Properties of Epitaxial Ferroelectric Lead-Free 0.5[Ba(Ti(0.8)Zr(0.2))O(3)]-0.5(Ba(0.7)Ca(0.3))TiO(3) Films
por: Cucciniello, Nicholas, et al.
Publicado: (2023)

Comparing the Efficacy of Latanoprost (0.005%), Bimatoprost (0.03%), Travoprost (0.004%), and Timolol (0.5%) in the Treatment of Primary Open Angle Glaucoma
por: Mishra, Deepak, et al.
Publicado: (2014)

A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye
por: Park, Yuli, et al.
Publicado: (2017)

Comparative analysis of efficacy of lignocaine 1.5 mg/kg and two different doses of dexmedetomidine (0.5 μg/kg and 1 μg/kg) in attenuating the hemodynamic pressure response to laryngoscopy and intubation
por: Gulabani, Michell, et al.
Publicado: (2015)

Li(0.5)Al(0.5)Mg(2)(MoO(4))(3)
por: Ennajeh, Ines, et al.
Publicado: (2013)

The efficacy of adding dexamethasone, midazolam, or epinephrine to 0.5% bupivacaine in supraclavicular brachial plexus block
por: El-Baradey, Ghada F., et al.
Publicado: (2014)

Effect of Poling on Multicatalytic Performance of 0.5Ba(Zr(0.2)Ti(0.8))O(3)-0.5(Ba(0.7)Sr(0.3))TiO(3) Ferroelectric Ceramic for Dye Degradation
por: Gaur, Akshay, et al.
Publicado: (2022)

Influence of Grain Size on Dielectric Behavior in Lead-Free 0.5 Ba(Zr(0.2)Ti(0.8))O(3)–0.5 (Ba(0.7)Ca(0.3))TiO(3) Ceramics
por: Ene, Vladimir Lucian, et al.
Publicado: (2023)

The Efficacy of Two Intravenous Sedative Drugs in Management of Uncooperative Children for Dental Treatments
por: Kaviani, Nasser, et al.
Publicado: (2015)

Efficacy of 0.5 mg/kg of propofol at the end of anesthesia to reduce the incidence of emergence agitation in children undergoing general anesthesia with sevoflurane
por: Ramlan, Andi Ade Wijaya, et al.
Publicado: (2020)

Annealing-Dependent Morphotropic Phase Boundary in the BiMg(0.5)Ti(0.5)O(3)–BiZn(0.5)Ti(0.5)O(3) Perovskite System
por: Cardoso, João Pedro V., et al.
Publicado: (2022)

577. Incidence and Outcomes of Positive Outpatient Surveillance Blood Cultures in Hematopoietic Stem Cell Transplant (HSCT) Patients with Graft Versus Host Disease (GvHD) On High Dose ≥ 0.5 mg/kg/day (HD) and Low Dose < 0.5mg/kg/day (LD) Steroid Therapy
por: Perreault, Sarah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3e4askn0gtg3gnomj8iedgfbfi